Kamada (KMDA) EPS (Basic) Growth (3y) (2015 - 2026)
Kamada (KMDA) EPS (Basic) Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.38 Bn | 43.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.66 Bn | 40.00 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 32.33 Bn | 30.66 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.04 Bn | 19.37 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Kamada | 468.67 Mn | 439.19 Mn | 22.47 Mn | 58.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.88% |
| Mar 31, 2026 | 1,319.43% |
| Dec 31, 2025 | 12.24% |
| Sep 30, 2025 | 2,029.34% |
| Jun 30, 2025 | -89.23% |
| Mar 31, 2025 | 57.99% |
| Dec 31, 2024 | 29.65% |
| Sep 30, 2024 | 213.27% |
| Jun 30, 2024 | -83.78% |
| Mar 31, 2024 | -5.44% |
| Dec 31, 2023 | 40.42% |
| Sep 30, 2023 | -24.86% |
| Jun 30, 2023 | -22.17% |
| Mar 31, 2023 | -26.00% |
| Dec 31, 2022 | -18.33% |
| Sep 30, 2022 | -95.47% |
| Jun 30, 2022 | 718.98% |
| Mar 31, 2022 | -30.60% |
| Dec 31, 2021 | -30.93% |
| Sep 30, 2021 | -31.07% |